1
|
Vivier D, Soussia IB, Rodrigues N, Lolignier S, Devilliers M, Chatelain FC, Prival L, Chapuy E, Bourdier G, Bennis K, Lesage F, Eschalier A, Busserolles J, Ducki S. Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity. J Med Chem 2017; 60:1076-1088. [DOI: 10.1021/acs.jmedchem.6b01285] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Delphine Vivier
- Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France
| | - Ismail Ben Soussia
- Labex
ICST, Institut de Pharmacologie Moléculaire et Cellulaire, UMR CNRS 7275, Université Côte d’Azur, F-06560 Valbonne, France
| | - Nuno Rodrigues
- Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France
| | - Stéphane Lolignier
- Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France
| | - Maïly Devilliers
- Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France
| | - Franck C. Chatelain
- Labex
ICST, Institut de Pharmacologie Moléculaire et Cellulaire, UMR CNRS 7275, Université Côte d’Azur, F-06560 Valbonne, France
| | - Laetitia Prival
- Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France
| | - Eric Chapuy
- Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France
| | - Geoffrey Bourdier
- Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France
| | - Khalil Bennis
- Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France
| | - Florian Lesage
- Labex
ICST, Institut de Pharmacologie Moléculaire et Cellulaire, UMR CNRS 7275, Université Côte d’Azur, F-06560 Valbonne, France
| | - Alain Eschalier
- Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France
- CHU Clermont-Ferrand, Service de Pharmacologie, F-63003 Clermont-Ferrand, France
| | - Jérôme Busserolles
- Université Clermont Auvergne, Inserm, Neuro-Dol, F-63000 Clermont-Ferrand, France
| | - Sylvie Ducki
- Université Clermont Auvergne, CNRS, SIGMA Clermont, ICCF, F-63000 Clermont-Ferrand, France
| |
Collapse
|
2
|
Vivier D, Bennis K, Lesage F, Ducki S. Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target? J Med Chem 2015; 59:5149-57. [PMID: 26588045 DOI: 10.1021/acs.jmedchem.5b00671] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Potassium (K(+)) channels are membrane proteins expressed in most living cells that selectively control the flow of K(+) ions. More than 80 genes encode the K(+) channel subunits in the human genome. The TWIK-related K(+) channel (TREK-1) belongs to the two-pore domain K(+) channels (K2P) and displays various properties including sensitivity to physical (membrane stretch, acidosis, temperature) and chemical stimuli (signaling lipids, volatile anesthetics). The distribution of TREK-1 in the central nervous system, coupled with the physiological consequences of its opening and closing, leads to the emergence of this channel as an attractive therapeutic target. We review the TREK-1 channel, its structural and functional properties, and the pharmacological agents (agonists and antagonists) able to modulate its gating.
Collapse
Affiliation(s)
- Delphine Vivier
- Université Clermont Auvergne, ENSCCF, Institut de Chimie de Clermont-Ferrand, BP 10448, F-63000 Clermont-Ferrand, France.,CNRS, UMR6296, ICCF, F-63171 Aubiere, France
| | - Khalil Bennis
- Université Clermont Auvergne, ENSCCF, Institut de Chimie de Clermont-Ferrand, BP 10448, F-63000 Clermont-Ferrand, France.,CNRS, UMR6296, ICCF, F-63171 Aubiere, France
| | - Florian Lesage
- Labex ICST, Institut de Pharmacologie Moléculaire et Cellulaire, UMR CNRS 7275, Université de Nice Sophia Antipolis, F-06560 Valbonne, France
| | - Sylvie Ducki
- Université Clermont Auvergne, ENSCCF, Institut de Chimie de Clermont-Ferrand, BP 10448, F-63000 Clermont-Ferrand, France.,CNRS, UMR6296, ICCF, F-63171 Aubiere, France
| |
Collapse
|